rs148276213
Positions:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2
The NM_020223.4(FAM20C):c.1228T>A(p.Ser410Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00596 in 1,535,878 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0057 ( 13 hom., cov: 33)
Exomes 𝑓: 0.0060 ( 40 hom. )
Consequence
FAM20C
NM_020223.4 missense
NM_020223.4 missense
Scores
1
10
6
Clinical Significance
Conservation
PhyloP100: 7.07
Genes affected
FAM20C (HGNC:22140): (FAM20C golgi associated secretory pathway kinase) This gene encodes a member of the family of secreted protein kinases. The encoded protein binds calcium and phosphorylates proteins involved in bone mineralization. Mutations in this gene are associated with the autosomal recessive disorder Raine syndrome. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
PM1
In a region_of_interest Kinase domain (size 211) in uniprot entity FA20C_HUMAN there are 18 pathogenic changes around while only 4 benign (82%) in NM_020223.4
BP4
Computational evidence support a benign effect (MetaRNN=0.015020758).
BP6
Variant 7-256004-T-A is Benign according to our data. Variant chr7-256004-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 289269.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00575 (875/152224) while in subpopulation NFE AF= 0.00653 (444/68010). AF 95% confidence interval is 0.00603. There are 13 homozygotes in gnomad4. There are 489 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 13 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FAM20C | NM_020223.4 | c.1228T>A | p.Ser410Thr | missense_variant | 6/10 | ENST00000313766.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FAM20C | ENST00000313766.6 | c.1228T>A | p.Ser410Thr | missense_variant | 6/10 | 1 | NM_020223.4 | P1 | |
FAM20C | ENST00000515795.1 | n.885T>A | non_coding_transcript_exon_variant | 3/7 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00576 AC: 876AN: 152106Hom.: 13 Cov.: 33
GnomAD3 genomes
AF:
AC:
876
AN:
152106
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00481 AC: 674AN: 140078Hom.: 2 AF XY: 0.00492 AC XY: 370AN XY: 75224
GnomAD3 exomes
AF:
AC:
674
AN:
140078
Hom.:
AF XY:
AC XY:
370
AN XY:
75224
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00598 AC: 8275AN: 1383654Hom.: 40 Cov.: 32 AF XY: 0.00589 AC XY: 4020AN XY: 682786
GnomAD4 exome
AF:
AC:
8275
AN:
1383654
Hom.:
Cov.:
32
AF XY:
AC XY:
4020
AN XY:
682786
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00575 AC: 875AN: 152224Hom.: 13 Cov.: 33 AF XY: 0.00657 AC XY: 489AN XY: 74428
GnomAD4 genome
AF:
AC:
875
AN:
152224
Hom.:
Cov.:
33
AF XY:
AC XY:
489
AN XY:
74428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
17
ALSPAC
AF:
AC:
25
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
26
ExAC
AF:
AC:
83
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Lethal osteosclerotic bone dysplasia Pathogenic:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 09, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Molecular Genetics, Royal Melbourne Hospital | May 04, 2023 | European Non-Finnish population allele frequency is 0.5092% (rs148276213, 674/140078 alleles, 2 homozygotes in gnomAD v2.1). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.5.1, this variant is classified as LIKELY BENIGN. Following criteria are met: BS1 - |
Likely pathogenic, no assertion criteria provided | clinical testing | Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics | Jan 17, 2017 | The observed mutation is reported in 1000 Genomes and ExAC databases. The in silico prediction of the mutation is damaging by MutationTaster2 and PROVEAN. The given mutation is probably damaging by Polyphen2 and it is benign by SIFT. The dbSNP reference number of the given mutation is rs148276213. The proband, born of a third degree consanguinity, presented with facial dysmorphism, mild hypotonia and microcephaly. Her CT-scan report showed mild cortical atrophy. Her EEG and karyotype were normal. She was found normal for William syndrome. Her array CGH report showed no quantitative genomic imbalance. She was observed to have chronic constipation, hyperactive behavior, two episodes of seizures, delay in speech, delay in cognitive and motor milestones. Her MRI report showed corpus callosal dysgenesis with absent rostral area. She was also detected with intrauterine growth restriction (IUGR). She was born through Lower segment Cesarian section (LSCS). She presented no neonatal difficulties. Her parents were found to be heterozygous for this allele. - |
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | FAM20C: BS1, BS2 - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 30, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Uncertain
T
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Benign
T
Sift4G
Benign
T
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at